Loading...

Korean biotech firms are seen as undervalued by big investment firms

Image

10-Apr-17 Korean biotech companies are drawing much interest and investment from well-known foreign investors including Bain Capital, Goldman Sachs and the state-run Chinese company Tsinghua Tongfang Group. Korea biotech firms, according to one investor "are second to none, in terms of technology but their values have been underestimated due to the small size of the domestic market.” [image: Business Korea]

Read More

First Online Tele-Health Platform debuts in Malaysia

Image

10-Apr-17 DoctorOnCall debuts as Malaysia’s first online telehealth platform that connects patients with an extensive network of doctors and medical practitioners via audio or video call. DoctorOnCall.com.my has also become Malaysia’s first online prescription-based pharmacy, with average delivery times of 4-6 hours for areas within Kuala Lumpur and the Klang Valley, and 1-2 days for the rest of Malaysia. [image: Citizen Journalists Malaysia]

Read More

Takeda to initiate large scale dengue vaccine trial in Asia and Latin America

Image

06-Apr-17 In Japanese companies' largest study to date, Takeda will test an experimental dengue vaccine on 20,100 children and adolescents in eight countries in Latin America. Takeda said it has completed enrollment for a 20,000-subject dengue vaccine trial, the largest clinical study in its history, signalling the global ambitions of its vaccine business. [image: ET Healthworld]

Read More

Zuellig Pharma invests in first innovation centre in Singapore

Image

05-Apr-17 Singapore based Zuellig Pharma has launched Zuellig Health Solutions innovation centre, in Singapore and plans to invest over USD35 mn in the next five years. On why it chose Singapore for its new venture, CEO John Davison said: "We see many of our clients in the pharmaceutical and consumer health sector (such as) GlaxoSmithKline and AstraZeneca here in Singapore." [image: Zuellig Pharma]

Read More

Ericsson eyes Healthcare IoT in China with China Mobile, AstraZeneca

Image

27-Mar-17 Ericsson has partnered with China Mobile and AstraZeneca to connect healthcare equipment using NB-IoT technology. China Mobile’s Jiangsu branch and Ericsson will work together to trial new applications using cellular IoT technologies like NB-IoT and provide network terminal management to support equipment management. Additionally, AstraZeneca is also working with the Wuxi government to open a China Commercial Innovation Center. [image: Wireless Week / Ericsson].

Read More